Pharma Asset Strategy I - Personalized Medicine
This chapter focuses on Personalized Medicine, introducing types of Biomarkers and their use as endpoints in clinical trials. Also included is a case study on Tumor Mutational Burden.
Course curriculum
-
-
Personalized Medicine: Biomarkers and Endpoints (Full Lecture)
-
Supplemental Materials
-
Case Study - Tumor Mutational Burden
-
Personalized Medicine: Biomarkers and Endpoints (Free Preview)
FREE PREVIEW
-
About this course
- $99.00
- 4 lessons
- 0.5 hours of video content